ESTTA Tracking number:
`
`ESTTA1347634
`
`Filing date:
`
`03/21/2024
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`Proceeding no.
`
`91287565
`
`Party
`
`Correspondence
`address
`
`Submission
`
`Filer's name
`
`Filer's email
`
`Signature
`
`Date
`
`Defendant
`AltruBio Inc.
`
`JOHN C. CAIN
`MUNCK WILSON MANDALA, LLP
`1330 POST OAK BLVD., STE 2850
`HOUSTON, TX 77056
`UNITED STATES
`Primary email: fmtrademarks@munckwilson.com
`Secondary email(s): jcain@munckwilson.com, crifai@munckwilson.com
`832-615-2744
`
`Motion to Amend Application
`
`John C. Cain
`
`fmtrademarks@munckwilson.com, jcain@munckwilson.com, cri-
`fai@munckwilson.com
`
`/John C. Cain/
`
`03/21/2024
`
`Attachments
`
`Applicant Response to Bd Order Bausch with exhibits.pdf(3619844 bytes )
`
`

`

`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`
`------------------------------------------------------x
`
`
`
`
`
`
`:
`BAUSCH HEALTH IRELAND LIMITED, :
`
`
`
`
`
`
`:
`
`
`Opposer,
`
`
`:
`
`
`
`
`
`
`:
`
`vs.
`
`
`
`
`:
`
`
`
`
`
`
`:
`ALTRUBIO INC.,
`
`
`
`:
`
`
`
`
`
`
`:
`
`
`Applicant.
`
`
`:
`
`
`
`
`
`
`:
`------------------------------------------------------x
`
`
`
`
`Opposition No. 91287565
`
`RENEWED MOTION ON CONSENT TO AMEND APPLICATION
`AND SUSPEND PROCEEDINGS AND, IF ACCEPTED, TO
` WITHDRAW THE OPPOSITION
`
`Applicant, AltruBio Inc. (“Applicant”), files this response to the Board’s denial of the
`
`Motion on Consent to Amend Application and Suspend Proceedings and, if accepted to Withdraw
`
`the Opposition filed on February 13, 2024 (the “First Motion”).
`
`BACKGROUND
`
`In the First Motion, Applicant proposed (with Opposer’s consent) to modify the Class 5
`
`description of goods in the Application as shown below (new matter in bold):
`
`Class 5: a house mark for pharmaceutical preparations for use in the treatment of
`immunoregulatory diseases, inflammatory diseases, autoimmune diseases and cancers,
`excluding pharmaceutical preparations for the treatment of hemophilia, blood
`diseases, blood disorders, dermatologic conditions, and skin care disorders
`
`
`(hereafter, the “Proposed Amendment”).
`
`The Board denied the First Motion, without prejudice, on February 20, 2024, alleging that
`
`
`
`by requesting that the language “a house mark for” be added to Class 5, Applicant was
`
`impermissibly requesting that the identification set forth the provider of the goods. The Board then
`
`1
`
`

`

`
`
`suspended the opposition proceeding for thirty days, during which time period Applicant and
`
`Opposer were invited to file a revised motion to amend.
`
`
`
`Applicant respectfully asserts that the Proposed Amendment was in fact proper under
`
`USPTO rules and precedent. In support of this position, Applicant presents the below arguments
`
`and attaches additional evidence of house mark usage for Applicant’s Mark.
`
`APPLICANT’S RESPONSE TO BOARD’S ORDER ON MOTION ON CONSENT TO
`AMEND APPLICATION
`
`The USPTO will register a mark as a house mark when there is sufficient evidence of the
`
`mark being used as a house mark. TMEP 1402.03(b). This is a common practice in the
`
`pharmaceutical industry, with at least 200 marks currently registered on the Principal Register in
`
`Class 5 for pharmaceutical goods with “house mark” language in various forms. See, Exhibit 1.
`
`Many of these records include instances where the owner originally applied for a listing of goods
`
`in Class 5, then later amended the application to include “house mark” language. See, e.g., U.S.
`
`Trademark Registration Nos. 4493244, 4615527, 5682519, 5851798, 5614467, 6253614, and
`
`6653958 (copies of the TSDR for these registrations are attached as Exhibits 2 to 8).
`
`Indeed, the record for U.S. Trademark Registration No. 6653958 for the mark TRICIDA
`
`by Tricida, Inc., attached as Exhibit 8, is particularly instructive in this instance. The company
`
`originally filed under Class 5 for various pharmaceutical preparations, the application as published,
`
`and a Notice of Allowance issued for these goods. Id. However, before a Statement of Use was
`
`filed, Tricida, Inc. entered into an agreement with a third party under which Tricida, Inc. agreed to
`
`amend the Class 5 goods to include “a house mark for” language. See Exhibit 9, Petition to Director
`
`for Application No. 87931649. The Petition to the Director was granted, and Tricida, Inc. later
`
`filed the below specimen with its Statement of Use, which was accepted. Exhibit 8.
`
`2
`
`

`

`
`
`
`
`These records demonstrate that this type of amendment is routinely allowed during the
`
`prosecution of an application and found to not broaden the scope of the goods or require
`
`republication of the subject application. Thus, the Proposed Amendment is proper and should be
`
`allowed in this instance.
`
`The below specimens are currently on record with the Application, demonstrating use of
`
`the ALTRUBIO mark as a house mark on at least two of Applicant’s pharmaceutical products:
`
`3
`
`

`

`
`
`
`
`
`
`Applicant respectfully asserts that these photographs demonstrate house mark usage for
`
`Applicant’s Mark. However, additional evidence of Applicant’s use of the ALTRUBIO mark as a
`
`house mark is attached as Exhibit 10. With this additional evidence, Applicant believes that there
`
`is sufficient evidence to show broad use of the ALTRUBIO mark as a house mark, as required
`
`under 37 C.F.R. §2.61(b).
`
`RENEWED MOTION
`
`Applicant therefore renews its motion, with the consent of Opposer Bausch Health Ireland
`
`Limited (“Opposer”), to amend the Class 5 description of goods in the Application as originally
`
`submitted. Because the proposed amendment is in the nature of a limitation, no re-publication
`
`should be required, and the amendment therefore should be permissible.
`
`The parties also jointly renew their motion to suspend the above-captioned opposition
`
`proceeding pending review by the Board of the proposed amendment to the Application. The
`
`parties further consent that upon the approval and entry of the proposed amendment to the
`
`Application, the opposition proceeding and all claims asserted therein shall be dismissed.
`
`
`
`
`
`
`
`
`
`4
`
`

`

`
`
`SO STIPULATED AND AGREED, effective as of the last date of the signatures below.
`
`
`
`
`
`
`
`
`
`
`ALTRUBIO INC.
`
`March 21, 2024
`
`/John C. Cain/
`By:
` John C. Cain
`
`MUNCK WILSON MANDALA, LLP
`1330 Post Oak Blvd., Ste 2850
`Houston, TX 77056
`Phone: 832 615 2744
`jcain@munckwilson.com
`
`Attorney for Applicant AltruBio Inc.
`
`
`
`
`
`BAUSCH HEALTH IRELAND LIMITED
`
`March 21, 2024
`
`/Kelli A. Ovies/
`By:
`Kelli A. Ovies
`
`WOMBLE BOND DICKINSON (US) LLP
`555 Fayetteville Street, Suite 1100
`Raleigh, North Carolina 27601
`Phone: 919-755-2100
`Kelli.Ovies@wbd-us.com
`
`Attorney for Opposer Bausch Health Ireland
`Limited
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`5
`
`

`

`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on the date set forth below, a true and correct copy of the
`foregoing MOTION ON CONSENT TO AMEND APPLICATION AND
`SUSPEND PROCEEDINGS AND, IF ACCEPTED, TO WITHDRAW THE
`OPPOSITION was served on counsel for Opposer by email at the following address of
`record:
`
`tmdocketing@wbd-us.com
`evan.fultz@wbd-us.com
`kelli.ovies@wbd-us.com
`alice.rogers@wbd-us.com
`tmdocketing@bauschhealth.com
`
`
`
`
`
`/s/ Mandy Morgan
`Mandy Morgan
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`6
`
`

`

`Exhibit 1
`Exhibit 1
`
`

`

`Search results from 1 to 500
`Search term
`
`Serial Number
`
`Word
`mark
`
`Image
`
`Status
`
`Goods/Services (Truncated)
`
`Basis
`
`Filed Date
`
`Int. Class
`
`1 79304149
`
`STARPHAR
`MA
`
`Image for 79304149 Live
`
`IC 005: House mark for a full line of pharmaceuticals, drugs and diagnostic
`preparations for medical and veterinary purposes; House mark for a full line of
`chemical and biological preparations for medical and veterinary purposes; House
`mark for a full line of polyvalent compounds, synthetic molecules and dendrimers for
`medical and veterinary purposes.
`
`66a
`
`2020-12-
`15T00:00:0
`0
`
`IC 005
`
`2 79185967
`
`ALTAN
`PHARMA
`
`Image for 79185967 Live
`
`IC 005: House mark for a full line of pharmaceuticals and pharmaceutical
`preparations.
`
`2016-02-
`19T00:00:0
`0
`
`IC 005
`
`66a
`
`3 76678965
`
`FERRING
`
`Image for 76678965 Live
`
`IC 005: HOUSE MARK FOR PHARMACEUTICALS AND PHARMACEUTICAL
`PREPARATIONS USED TO TREAT DISEASES AND CONDITIONS IN THE AREAS OF
`ENDOCRINOLOGY, UROLOGY, INFERTILITY, AND CHRONIC BOWEL DISEASE, FOR
`TREATMENT OF DIABETES INSIPIDUS, ENURESIS, BED WETTING, AND ARTHRITIS, AND
`FOR USE AS A DIAGNOSTIC AGENT AND THERAPEUTIC AGENT FOR HORMONAL
`DISORDERS.
`
`1a
`
`2007-07-
`02T00:00:0
`0
`
`IC 005
`
`IC 005: HOUSE MARK FOR A FULL LINE OF PHARMACEUTICALS; AND
`PHARMACEUTICALS, NAMELY, PHARMACEUTICAL PREPARATIONS FOR USE IN
`PREVENTING OR TREATING CONDITIONS, DISEASES, OR DISORDERS OF THE
`CARDIOVASCULAR, CENTRAL NERVOUS, DERMATOLOGIC, ENDOCRINE, GASTRIC OR
`GASTROENTERIC, HEMATOLOGIC, IMMUNOLOGIC, INFLAMMATORY, OSTEOLOGIC,
`OR RESPIRATORY SYSTEMS; PHARMACEUTICAL PREPARATIONS FOR USE IN
`PREVENTION OR TREATMENT OF ALLERGIES OR ALLERGIC RESPONSES, METABOLIC
`DISORDERS, PSYCHIATRIC OR EMOTIONAL DISORDERS, INFECTION OR INFECTIOUS
`DISEASES, OR PAIN.
`
`2006-12-
`15T00:00:0
`0
`
`IC 005
`
`1a
`
`4 77064903
`
`CADISTA
`
`Image for 77064903 Live
`
`Owner
`Starpharma Pty
`Limited
`(PROPRIETARY
`LIMITED
`COMPANY;
`AUSTRALIA); PO
`BOX 2022,
`PRESTON VIC
`3072,
`AUSTRALIA
`
`Altan Pharma
`Ltd. (limited
`company (ltd.);
`IRELAND); The
`Lennox
`Building,, 50
`South
`Richmond
`Street D02FK02
`Dublin 2,
`IRELAND
`Ferring B.V.
`(LIMITED
`LIABILITY
`COMPANY;
`NETHERLANDS);
`Polaris Avenue
`144,
`Hoofddorp,
`2132 JX,
`NETHERLANDS
`JUBILANT
`CADISTA
`PHARMACEUTIC
`ALS INC.
`(CORPORATION
`; DELAWARE,
`USA); 207 KILEY
`DRIVE,
`SALISBURY,
`MARYLAND
`21804, UNITED
`STATES
`
`Priority
`Date
`
`Reg. Date
`
`Reg. No.
`
`Reg. Type
`
`Supplemental Reg. Date
`
`2022-04-12
`
`6696074
`
`PRINCIPAL
`
`2016-01-11 2017-10-24
`
`5314158
`
`PRINCIPAL
`
`2009-08-04
`
`3662266
`
`PRINCIPAL
`
`2008-05-13
`
`3427622
`
`PRINCIPAL
`
`

`

`Serial Number
`
`Word
`mark
`
`Image
`
`Status
`
`Goods/Services (Truncated)
`
`Basis
`
`Filed Date
`
`Int. Class
`
`Owner
`
`Priority
`Date
`
`Reg. Date
`
`Reg. No.
`
`Reg. Type
`
`Supplemental Reg. Date
`
`IC 005: House mark for medicated, medical, pharmaceutical, dental and sanitary
`preparations and products, namely, medicated skin care preparations, cleansers for
`skin and wounds, anti-fungal creams and powders, anti-microbial soap, no-rinse
`head and body cleanser; wound care products namely, dressings, adhesive bandages,
`medical and surgical adhesive tape, gauze, [ nylon strips, ] topical first aid gel, topical
`gel for medical and therapeutic treatment of wound care; sanitary belts, sanitary
`pads, [ tampons, ] oral wound rinse, pre-moistened medical wipes, [ air deodorizers,
`] disinfectants for hygienic and sanitary purposes, disinfectants for medical
`instruments, incontinence pads, adult diapers, nutritional and dietary supplements
`in powder and liquid form, disinfectant wipes made of fabric or paper, skin lotions,
`skin creams and skin ointments for medical use, cataract eye care kits composed of
`eye washes and protective glasses; disposable liners for use with disposable
`incontinent...
`
`2006-01-
`12T00:00:0
`0
`
`IC 005
`
`1a
`
`5 78790069
`
`MEDLINE
`
`Image for 78790069 Live
`
`6 78155052
`
`FUTURE
`CEUTICALS Image for 78155052 Live
`
`IC 005: HOUSE MARK FOR DIETARY AND NUTRITIONAL SUPPLEMENTS.
`
`1a
`
`2002-08-
`16T00:00:0
`0
`
`IC 005
`
`7 75404967
`
`CURAD
`
`Image for 75404967 Live
`
`IC 005: house mark for a full line of healthcare bandage products, namely, bandage
`strips and medical adhesive tape for skin wounds and skin protection designed for
`fingers, knees, elbows and other parts of the body, adhesive tape [ and non-
`professional first aid kits comprised of bandages, tape, antibiotics, antiseptics,
`cleansing pads and accessories used in giving first aid ] [, and sanitary napkins ].
`
`1997-12-
`15T00:00:0
`0
`
`IC 005
`
`1a
`
`8 87608314
`
`Image for 87608314 Live
`
`IC 005: House mark for pharmaceutical preparations for treating diseases and
`disorders affecting the eye.
`
`1a
`
`2017-09-
`14T00:00:0
`0
`
`IC 005
`
`MEDLINE
`INDUSTRIES, LP
`(LIMITED
`PARTNERSHIP;
`ILLINOIS, USA);
`THREE LAKES
`DRIVE,
`NORTHFIELD,
`ILLINOIS 60093,
`UNITED STATES
`
`VDF
`FUTURECEUTIC
`ALS, INC.
`(CORPORATION
`; ILLINOIS, USA);
`2692 N. State
`Rt. 1-17,
`Momence,
`ILLINOIS 60954,
`UNITED STATES
`
`MEDLINE
`INDUSTRIES, LP
`(LIMITED
`PARTNERSHIP;
`ILLINOIS, USA);
`THREE LAKES
`DRIVE,
`NORTHFIELD,
`ILLINOIS 60093,
`UNITED STATES
`
`Ocugen, Inc.
`(CORPORATION
`; DELAWARE,
`USA); 11 Great
`Valley Pkwy,
`Malvern,
`PENNSYLVANIA
`19355, UNITED
`STATES
`
`2007-11-27
`
`3343906
`
`PRINCIPAL
`
`2004-10-19
`
`2895123
`
`PRINCIPAL
`
`1999-07-27
`
`2265690
`
`PRINCIPAL
`
`2018-08-14
`
`5542529
`
`PRINCIPAL
`
`

`

`Serial Number
`
`Word
`mark
`
`Image
`
`Status
`
`Goods/Services (Truncated)
`
`Basis
`
`Filed Date
`
`Int. Class
`
`Owner
`
`Priority
`Date
`
`Reg. Date
`
`Reg. No.
`
`Reg. Type
`
`Supplemental Reg. Date
`
`9 88981401
`
`Image for 88981401 Live
`
`IC 005: House mark for pharmaceuticals for the treatment of cystic fibrosis; house
`mark for pharmaceuticals for the treatment of genetic diseases and disorders.
`
`1a
`
`2018-07-
`30T00:00:0
`0
`
`IC 005
`
`10 78454524
`
`V
`
`Image for 78454524 Live
`
`IC 005: house mark for a full line of pharmaceutical preparations and dermatological
`pharmaceutical products.
`
`1a
`
`2004-07-
`21T00:00:0
`0
`
`IC 005
`
`11 78308411
`
`VALEANT
`
`Image for 78308411 Live
`
`IC 005: House mark for a full line of pharmaceutical preparations and dermatological
`products for humans.
`
`1a
`
`2003-10-
`02T00:00:0
`0
`
`IC 005
`
`Calithera
`Biosciences, Inc.
`(CORPORATION
`; DELAWARE,
`USA); 343
`Oyster Point
`Blvd, Suite 200,
`South San
`Francisco,
`CALIFORNIA
`94080, UNITED
`STATES
`
`Valeant
`Pharmaceutical
`s International
`(CORPORATION
`; DELAWARE,
`USA); 400
`Somerset
`Corporate Blvd.,
`Legal Dept.,
`Bridgewater,
`NEW JERSEY
`08807, UNITED
`STATES
`
`VALEANT
`PHARMACEUTIC
`ALS
`INTERNATIONA
`L
`(CORPORATION
`; DELAWARE,
`USA); 400
`Somerset
`Corporate Blvd.,
`Legal Dept.,
`Bridgewater,
`NEW JERSEY
`08807, UNITED
`STATES
`
`2021-06-08
`
`6382036
`
`PRINCIPAL
`
`2006-09-12
`
`3143144
`
`PRINCIPAL
`
`2008-05-27
`
`3437512
`
`PRINCIPAL
`
`

`

`Serial Number
`
`Word
`mark
`
`Image
`
`Status
`
`Goods/Services (Truncated)
`
`Basis
`
`Filed Date
`
`Int. Class
`
`Owner
`
`Priority
`Date
`
`Reg. Date
`
`Reg. No.
`
`Reg. Type
`
`Supplemental Reg. Date
`
`12 78317757
`
`GLENMAR
`K
`
`Image for 78317757 Live
`
`IC 005: House mark for pharmaceutical and chemical preparations.
`
`1a
`
`2003-10-
`23T00:00:0
`0
`
`IC 005
`
`PAR
`PHARMAC
`EUTICAL
`
`13 78405599
`
`Image for 78405599 Live
`
`IC 005: House mark for a full line of pharmaceuticals for human use.; IC 035:
`Outsourcing services for others in the field of pharmaceuticals.; IC 040: Manufacture
`of pharmaceutical products to the order and specification of others.; IC 042:
`Research and development of pharmaceutical products for others.
`
`1a
`
`2004-04-
`21T00:00:0
`0
`
`IC 005 IC 035 IC
`040 IC 042
`
`14 78417344
`
`Image for 78417344 Live
`
`IC 005: House mark for a full line of pharmaceuticals except veterinary preparations. 44e
`
`2004-05-
`12T00:00:0
`0
`
`IC 005
`
`15 87159067
`
`UROVANT Image for 87159067 Live
`
`IC 005: Pharmaceutical and biological preparations used in the treatment of
`urological or metabolic conditions, disorders and diseases; House mark for
`pharmaceutical and biological preparations used in the treatment of urological or
`metabolic conditions, disorders and diseases.
`
`2016-09-
`01T00:00:0
`0
`
`IC 005
`
`44e
`
`GLENMARK
`PHARMACEUTIC
`ALS INC., USA
`(CORPORATION
`; DELAWARE,
`USA); 750
`CORPORATE
`DRIVE, LEGAL
`DEPARTMENT,
`MAHWAH, NEW
`JERSEY 07430,
`UNITED STATES
`
`PAR
`PHARMACEUTIC
`AL, INC.
`(CORPORATION
`; NEW YORK,
`USA); 1 RAM
`RIDGE ROAD,
`CHESTNUT
`RIDGE, NEW
`YORK 10977,
`UNITED STATES
`
`Torrent
`Pharmaceutical
`s Limited
`(LIMITED
`COMPANY;
`INDIA); Torrent
`House, Near
`Dinesh Hall, Off
`Ashram Road,
`Ahmedabad
`380009, INDIA
`
`UROVANT
`SCIENCES
`GMBH
`(COMPANY;
`SWITZERLAND);
`Gottharstrasse
`3, 4th Floor,
`Zug, CH-6300,
`SWITZERLAND
`
`2006-09-19
`
`3146215
`
`PRINCIPAL
`
`2006-07-18
`
`3118058
`
`PRINCIPAL
`
`2008-03-25
`
`3401689
`
`PRINCIPAL
`
`2019-02-12
`
`5672102
`
`PRINCIPAL
`
`

`

`Serial Number
`
`Word
`mark
`
`Image
`
`Status
`
`Goods/Services (Truncated)
`
`Basis
`
`Filed Date
`
`Int. Class
`
`Owner
`
`Priority
`Date
`
`Reg. Date
`
`Reg. No.
`
`Reg. Type
`
`Supplemental Reg. Date
`
`IC 010: Hearing aids; finger guards for medical purposes; pacifiers for babies; ice bag
`pillows for medical purposes; triangular elastic bandages; triangular anelastic
`bandages; supportive bandages; surgical catguts; feeding cups for medical purposes;
`dropping pipettes for medical purposes; teats in the nature of feeding bottles;
`medical ice bags; medical ice bag holders; baby bottles; nursing bottles;
`contraceptive apparatus, non-chemical; artificial tympanic membranes; prosthetics
`or fillings materials, not for dental use, namely, artificial materials for use in the
`replacement of bones, prosthetic and orthopedic joint implants made of artificial
`materials; ear plugs for sleeping; ear plugs for soundproofing; esthetic massage
`apparatus for commercial use; supportive and corrective elastic compression bands
`for muscles or joints of human beings or animals; house mark for a full line of
`medical apparatus and instruments for the treatment of disease; electric massage
`apparatus for...
`
`2020-05-
`20T00:00:0
`0
`
`IC 010 IC 042 IC
`005 IC 044 IC 009
`
`44e
`
`TOWA
`PHARMAC
`EUTICAL
`EUROPE
`
`16 88925250
`
`Image for 88925250 Live
`
`17 77614609
`
`SHIONOGI
`
`Image for 77614609 Live
`
`IC 005: House mark for a full line of pharmaceutical preparations, dietetic and
`nutritional substances; vitamins; medications for pain relief.; IC 035: Wholesale
`distributorship services of pharmaceutical preparations, dietetic and nutritional
`substances, vitamins, and medications for pain relief.
`
`2008-11-
`14T00:00:0
`0
`
`1a
`
`IC 005 IC 035
`
`LEUCADIA
`PHARMAC
`EUTICALS
`
`18 86794587
`
`Image for 86794587 Live
`
`IC 005: a house mark for a full line of pharmaceutical preparations.
`
`1a
`
`2015-10-
`21T00:00:0
`0
`
`IC 005
`
`TOWA
`PHARMACEUTIC
`AL CO., LTD.
`(CORPORATION
`; JAPAN); 2-11,
`Shinbashi-cho,
`Kadoma, Osaka,
`571-8580,
`JAPAN
`
`Shionogi & Co.,
`Ltd.
`(CORPORATION
`; JAPAN); 1-8,
`Doshomachi 3-
`chome, Chuo-
`ku, Osaka, 541-
`0045, JAPAN
`
`HIKMA
`PHARMACEUTIC
`ALS USA INC.
`(CORPORATION
`; DELAWARE,
`USA); 200
`CONNELL
`DRIVE, 4TH
`FLOOR,
`BERKELEY
`HEIGHTS, NEW
`JERSEY 07922,
`UNITED STATES
`
`2020-03-26 2023-11-21
`
`7220834
`
`PRINCIPAL
`
`2011-04-12
`
`3944828
`
`PRINCIPAL
`
`2019-09-03
`
`5851798
`
`PRINCIPAL
`
`

`

`Serial Number
`
`Word
`mark
`
`Image
`
`Status
`
`Goods/Services (Truncated)
`
`Basis
`
`Filed Date
`
`Int. Class
`
`Owner
`
`Priority
`Date
`
`Reg. Date
`
`Reg. No.
`
`Reg. Type
`
`Supplemental Reg. Date
`
`19 73781811
`
`TEVA
`
`Image for 73781811 Live
`
`IC 005: HOUSE MARK FOR A FULL LINE OF PHARMACEUTICAL, VETERINARY AND
`SANITARY PREPARATIONS.
`
`44e
`
`1989-02-
`17T00:00:0
`0
`
`IC 005
`
`IC 005: House mark used for a line of pharmaceuticals used in connection with anti-
`aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and
`conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction,
`breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma
`and decongestant formulations, and pharmaceutical preparations to treat and
`prevent glaucoma; ocular wetting solutions, namely, eye drops, artificial tears and
`gels for the treatment of minor ocular inflammations and allergic conditions;
`Pharmaceutical preparations for the treatment of neurological disorders, muscle
`dystonias, smooth muscle disorders, autonomic nerve disorders, headaches,
`hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain;
`dermatological formulations, namely, medicated dry skin lotions and creams, acne
`medications and medicated skin lighteners; Oral, transdermal, injectable and
`intravaginal contraceptive...
`
`2018-01-
`03T00:00:0
`0
`
`1a
`
`IC 005 IC 010
`
`20 87742107
`
`ALLERGAN Image for 87742107 Live
`
`21 87939287
`
`CIVICA
`
`Image for 87939287 Live
`
`IC 040: Custom manufacture of pharmaceuticals for others.; IC 005: House mark for a
`full line of pharmaceutical products for human use.; IC 044: Providing educational
`information in the field of pharmaceuticals; medical consulting services in the field of
`pharmaceuticals; providing healthcare information by telephone, the Internet, global
`computer networks, and electronic means in the field of pharmaceuticals.
`
`1a
`
`2018-05-
`29T00:00:0
`0
`
`IC 040 IC 005 IC
`044
`
`TEVA
`PHARMACEUTIC
`AL INDUSTRIES
`LTD.
`(COMPANY;
`ISRAEL); Science
`Based
`Industries
`Campus, 124
`Dvora HaNevi'a
`Street, Tel Aviv,
`6944020,
`ISRAEL
`
`Allergan Sales,
`LLC (LIMITED
`LIABILITY
`COMPANY;
`DELAWARE,
`USA); 5 Giralda
`Farms,
`Madison, NEW
`JERSEY 07940,
`UNITED STATES
`
`Civica, Inc.
`(nonprofit/nons
`tock
`corporation;
`DELAWARE,
`USA); 2912
`Executive
`Parkway, Suite
`325, Lehi, UTAH
`84043, UNITED
`STATES
`
`1989-11-28
`
`1567918
`
`PRINCIPAL
`
`2021-07-13
`
`6420206
`
`PRINCIPAL
`
`2019-12-17
`
`5938996
`
`PRINCIPAL
`
`

`

`Serial Number
`
`Word
`mark
`
`Image
`
`Status
`
`Goods/Services (Truncated)
`
`Basis
`
`Filed Date
`
`Int. Class
`
`22 90782103
`
`BRECKENRI
`DGE
`
`Image for 90782103 Live
`
`IC 005: House mark for a full line of pharmaceuticals, dietary supplements and
`medical foods for human consumption.; IC 035: Distributorship services featuring
`pharmaceuticals, dietary supplements and medical foods for human consumption.
`
`1a
`
`2021-06-
`18T00:00:0
`0
`
`IC 005 IC 035
`
`23 90792334
`
`EXELA
`
`Image for 90792334 Live
`
`IC 040: Manufacture of pharmaceutical products for others.; IC 005: House mark for
`pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal,
`cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological,
`ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric, and
`immune system diseases and disorders, excluding pharmaceuticals that are directly
`targeted for the treatment of cancer.; IC 035: Marketing services.; IC 042:
`Pharmaceutical drug development services.
`
`2021-06-
`24T00:00:0
`0
`
`IC 040 IC 005 IC
`035 IC 042
`
`1a
`
`24 90792345
`
`EXELA
`
`Image for 90792345 Live
`
`IC 040: Manufacture of pharmaceutical products for others.; IC 005: House mark for
`pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal,
`cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological,
`ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric, and
`immune system diseases and disorders, excluding pharmaceuticals that are directly
`targeted for the treatment of cancer.; IC 035: Marketing services.; IC 042:
`Pharmaceutical drug development services.
`
`2021-06-
`24T00:00:0
`0
`
`IC 040 IC 005 IC
`035 IC 042
`
`1a
`
`25 85163704
`
`ZX
`PHARMA
`
`Image for 85163704 Live
`
`IC 005: House mark for full line of pharmaceutical preparations and nutritional
`supplements.
`
`1a
`
`2010-10-
`28T00:00:0
`0
`
`IC 005
`
`Owner
`Breckenridge
`Pharmaceutical,
`Inc.
`(CORPORATION
`; FLORIDA,
`USA); 15
`Massirio Drive,
`Suite 201,
`Berlin,
`CONNECTICUT
`06037, UNITED
`STATES
`Exela Holdings,
`Inc.
`(CORPORATION
`; DELAWARE,
`USA); 1245
`Blowing Rock
`Blvd., Lenoir,
`NORTH
`CAROLINA
`28645, UNITED
`STATES
`Exela Holdings,
`Inc.
`(CORPORATION
`; DELAWARE,
`USA); 1245
`Blowing Rock
`Blvd., Lenoir,
`NORTH
`CAROLINA
`28645, UNITED
`STATES
`
`SOCIÉTÉ DES
`PRODUITS
`NESTLÉ S.A.
`(SOCIÉTÉ
`ANONYME (SA);
`SWITZERLAND);
`AVENUE NESTLÉ
`55, VEVEY,
`1800,
`SWITZERLAND
`
`Priority
`Date
`
`Reg. Date
`
`Reg. No.
`
`Reg. Type
`
`Supplemental Reg. Date
`
`2022-12-27
`
`6933375
`
`PRINCIPAL
`
`2022-11-15
`
`6898482
`
`PRINCIPAL
`
`2022-11-15
`
`6898483
`
`PRINCIPAL
`
`2014-06-03
`
`4543755
`
`PRINCIPAL
`
`

`

`Serial Number
`
`Word
`mark
`
`Image
`
`Status
`
`Goods/Services (Truncated)
`
`Basis
`
`Filed Date
`
`Int. Class
`
`Owner
`
`Priority
`Date
`
`Reg. Date
`
`Reg. No.
`
`Reg. Type
`
`Supplemental Reg. Date
`
`26 87236048
`
`GENZYME Image for 87236048 Live
`
`IC 005: House mark for a full line of pharmaceuticals.
`
`2016-11-
`14T00:00:0
`0
`
`IC 005
`
`1a
`
`IC 005: Pharmaceuticals for the treatment of cancer, MRSA, sepsis, immunological
`diseases and disorders, and age-related diseases and disorders; drug delivery agents
`as a featured component of pharmaceuticals for the treatment of cancer, MRSA,
`sepsis, immunological diseases and disorders, and age-related diseases and
`disorders; house mark for pharmaceuticals and drug delivery agents; * all of the
`foregoing excluding radio enhancers for use with radiotherapy *.; IC 010: Medical
`apparatus and units for dosing, namely, drug delivery devices and systems; medical
`apparatus for introducing pharmaceutical preparations into the human body; * all of
`the foregoing excluding radio enhancers for use with radiotherapy *.
`
`2017-06-
`21T00:00:0
`0
`
`1a
`
`IC 005 IC 010
`
`27 87498798
`
`NANOTICS Image for 87498798 Live
`
`28 97612655
`
`MAXXEUS
`BY CTS
`
`Image for 97612655 Live
`
`IC 005: A house mark for human allograft tissue.
`
`2022-09-
`29T00:00:0
`0
`
`IC 005
`
`1a
`
`29 73433009
`
`Image for 73433009 Live
`
`IC 005: HOUSE MARK FOR A FULL LINE OF VITAMINS, MINERALS, MEDICINAL HERBS,
`MEDICINAL HERBAL TEAS, GINSENG, ANTLER, AND PHARMACEUTICAL
`PREPARATIONS.
`
`1a
`
`1983-06-
`30T00:00:0
`0
`
`IC 005
`
`Genzyme
`Corporation
`(CORPORATION
`;
`MASSACHUSETT
`S, USA); 450
`Water Street,
`Cambridge,
`MASSACHUSETT
`S 02142,
`UNITED STATES
`NaNotics, LLC
`(LIMITED
`LIABILITY
`COMPANY;
`DELAWARE,
`USA); 531
`Midvale Way,
`Mill Valley,
`CALIFORNIA
`94941, UNITED
`STATES
`
`Community
`Blood Center
`(non-profit
`corporation;
`OHIO, USA); 349
`S. Main Street,
`Dayton, OHIO
`45402, UNITED
`STATES
`
`TAK TAI
`GINSENG FIRM
`LTD.
`(CORPORATION
`; HONG KONG);
`201-205 WING
`LOK ST., WEST
`HONG KONG,
`HONG KONG
`
`2017-04-18
`
`5186642
`
`PRINCIPAL
`
`2021-08-17
`
`6451169
`
`PRINCIPAL
`
`2023-08-29
`
`7150868
`
`PRINCIPAL
`
`1985-09-03
`
`1357556
`
`PRINCIPAL
`
`

`

`Serial Number
`
`Word
`mark
`
`Image
`
`Status
`
`Goods/Services (Truncated)
`
`Basis
`
`Filed Date
`
`Int. Class
`
`Owner
`
`Priority
`Date
`
`Reg. Date
`
`Reg. No.
`
`Reg. Type
`
`Supplemental Reg. Date
`
`30 77193026
`
`CURAD
`
`Image for 77193026 Live
`
`IC 005: house mark for a full line of healthcare bandage products, namely, bandage
`strips and medical adhesive tape for skin wounds and skin protection designed for
`fingers, knees, elbows and other parts of the body, adhesive tape and non-
`professional first aid kits comprised of bandages, tape, antibiotics, antiseptics,
`cleansing pads and accessories used in giving first aid.
`
`1a
`
`2007-05-
`30T00:00:0
`0
`
`IC 005
`
`VALIDUS
`PHARMAC
`EUTICALS
`
`31 86814846
`
`Image for 86814846 Live
`
`IC 005: HOUSE MARK FOR PHARMACEUTICAL FORMULATIONS FOR HUMAN USE.
`
`1a
`
`2015-11-
`10T00:00:0
`0
`
`IC 005
`
`IC 005: House mark for prescription and non-prescription pharmaceutical
`preparations for human use; Full line pharmaceutical preparations for human use.; IC
`035: Wholesale distributorships featuring prescription and non-prescription
`pharmaceutical preparations, dietary supplements, and medical devices; wholesale
`ordering services in the field of prescription and non-prescription pharmaceutical
`preparations, dietary supplements, and medical devices; wholesale services by direct
`solicitation by sales agents in the field of prescription and non-prescription
`pharmaceutical preparations, dietary supplements, and medical devices; on-line
`wholesale store services featuring prescription and non-prescription pharmaceutical
`preparations, dietary supplements, and medical devices.
`
`2016-02-
`25T00:00:0
`0
`
`1a
`
`IC 005 IC 035
`
`32 86919173
`
`HRX
`
`Image for 86919173 Live
`
`33 86424518
`
`INTERCEPT Image for 86424518 Live
`
`IC 005: House mark for pharmaceutical preparations used to treat chronic liver and
`intestinal diseases.
`
`1a
`
`2014-10-
`15T00:00:0
`0
`
`IC 005
`
`MEDLINE
`INDUSTRIES, LP
`(LIMITED
`PARTNERSHIP;
`ILLINOIS, USA);
`THREE LAKES
`DRIVE,
`NORTHFIELD,
`ILLINOIS 60093,
`UNITED STATES
`VALIDUS
`PHARMACEUTIC
`ALS LLC
`(LIMITED
`LIABILITY
`COMPANY;
`DELAWARE,
`USA); 90 East
`Halsey Road,
`Suite 210,
`PARSIPPANY,
`NEW JERSEY
`07054, UNITED
`STATES
`HERCULES
`PHARMACEUTIC
`ALS, INC.
`(CORPORATION
`; NEW YORK,
`USA); 27
`SEAVIEW BLVD.,
`PORT
`WASHINGTON,
`NEW YORK
`11050, UNITED
`STATES
`Intercept
`Pharmaceutical
`s, Inc.
`(CORPORATION
`; DELAWARE,
`USA); 305
`Madison
`Avenue,
`Morristown,
`NEW JERSEY
`07960, UNITED
`STATES
`
`2008-07-08
`
`3460619
`
`PRINCIPAL
`
`2017-01-10
`
`5117183
`
`PRINCIPAL
`
`2019-06-25
`
`5784450
`
`PRINCIPAL
`
`2016-10-04
`
`5055185
`
`PRINCIPAL
`
`

`

`Serial Number
`
`Word
`mark
`
`Image
`
`Status
`
`Goods/Services (Truncated)
`
`Basis
`
`Filed Date
`
`Int. Class
`
`Owner
`
`Priority
`Date
`
`Reg. Date
`
`Reg. No.
`
`Reg. Type
`
`Supplemental Reg. Date
`
`34 78727009
`
`MGK
`
`Image for 78727009 Live
`
`IC 005: House mark for insecticides, pesticides, insect growth regulators for
`agricultural, industrial, institutional, commercial, residential, and household use, and
`insect repellants.
`
`1a
`
`2005-10-
`05T00:00:0
`0
`
`IC 005
`
`IC 009: House mark and brand name for laboratory apparatus and instruments for
`use in screening for osteoporosis, cervical cancer, and breast cancer.; IC 010: House
`mark and brand name for medical apparatus and instruments used for the detection,
`diagnosis, and treatment of breast cancer, namely, breast imaging systems, breast
`biopsy devices and biopsy image guidance systems, and systems for partial-breast
`irradiation; house mark and brand name for medical apparatus and instruments used
`for the detection and diagnosis of osteoporosis, namely, x-ray bone densitometers, x-
`ray imaging devices, and MRI diagnostic apparatus; house mark and brand name for
`medical apparatus and instruments used for the detection and diagnosis of cervical
`cancer, namely, a slide sample imaging system; house mark and brand name for
`medical apparatus and instruments used for surgery to correct excessive menstrual
`bleeding; house mark and brand name for medical apparatus and instruments used
`for the detection,...
`
`2007-11-
`30T00:00:0
`0
`
`IC 009 IC 010 IC
`005
`
`1a
`
`35 77341464
`
`HOLOGIC
`
`Image for 77341464 Live
`
`36 75601758
`
`TEVA
`
`Image for 75601758 Live
`
`IC 005: HOUSE MARK FOR A FULL LINE OF PHARMACEUTICAL PREPARATIONS AND
`CHEMICAL PREPARATIONS FOR MEDICAL PURPOSES.
`
`1a
`
`1998-12-
`08T00:00:0
`0
`
`IC 005
`
`McLaughlin
`Gormley King
`Company
`(CORPORATION
`; MINNESOTA,
`USA); 7325
`Aspen Ln N,
`MINNEAPOLIS,
`MINNESOTA
`55428, UNITED
`STATES
`
`Hologic, Inc.
`(CORPORATION
`; DELAWARE,
`USA); 250
`Campus Drive,
`Marlborough,
`MASSACHUSETT
`S 01752,
`UNITED STATES
`
`TEVA
`Pharmaceutical
`Industries Ltd.
`(CORPORATION
`; ISRAEL);
`Science Based
`Industries
`Campus, 124
`Dvora HaNevi'a
`Street, Tel Aviv,
`6944020,
`ISRAEL
`
`2007-03-27
`
`3221686
`
`PRINCIPAL
`
`2010-10-05
`
`3857248
`
`PRINCIPAL
`
`2000-05-30
`
`2353386
`
`PRINCIPAL
`
`

`

`Serial Number
`
`Word
`mark
`
`Image
`
`Status
`
`Goods/Services (Truncated)
`
`Basis
`
`Filed Date
`
`Int. Class
`
`Owner
`
`Priority
`Date
`
`Reg. Date
`
`Reg. No.
`
`Reg. Type
`
`Supplemental Reg. Date
`
`THE
`BINDING
`SITE
`
`37 74617549
`
`Image for 74617549 Live
`
`IC 010: house mark for a complete line of scientific instruments for use in laboratory
`research and diagnostic tests for humans and animals.; IC 005: diagnostic kits
`comprised of diagnostic reagents for laboratory use, calibrators, reagent plates,
`buffered solutions, diluent solutions, and serum.
`
`1a
`
`1995-01-
`03T00:00:0
`0
`
`IC 010 IC 005
`
`38 74642033
`
`TARO
`
`Image for 74642033 Live
`
`IC 005: house mark for dermatological preparations; pharmaceutical preparations,
`namely analgesics, nasal decongestants, antibiotics, antifungal preparations, nasal
`spray preparations, medical lubricating jelly, medicated skin care preparations,
`steroid preparations, steroid-antibiotic preparations, topical corticosteroid
`preparations, anticonvulsant preparations.
`
`1995-02-
`14T00:00:0
`0
`
`IC 005
`
`1a
`
`39 74568337
`
`Image for 74568337 Live
`
`IC 005: house mark for a full line of vitamins, herbal supplements, and nutritional
`supplements.
`
`1a
`
`40 74732720
`
`BLUE SEAL Image for 74732720 Live
`
`IC 005: house mark for medicated livestock and poultry feeds, and for medicated and
`non-medicated nutritional feed supplements for livestock and poultry.
`
`1a
`
`1994-08-
`31T00:00:0
`0
`
`IC 005
`
`1995-09-
`22T00:00:0
`0
`
`IC 005
`
`THE BINDING
`SITE GROUP,
`LTD.
`(CORPORATION
`; UNITED
`KINGDOM); 8
`Calthorpe Road,
`Birmingham,
`B151QT,
`UNITED
`KINGDOM
`
`TARO
`PHARMACEUTIC
`ALS U.S.A., INC.
`(CORPORATION
`; NEW YORK,
`USA); 3 SKYLINE
`DRIVE,
`HAWTHORNE,
`NEW YORK
`10532, UNITED
`STATES
`THRESHOLD
`ENTERPRISES
`LTD.
`(CORPORATION
`; DELAWARE,
`USA); 23 Janis
`Way, Scotts
`Valley,
`CALIFORNIA
`95066, UNITED
`STATES
`
`Kent Nutrition
`Group, Inc.
`(CORPORATION
`; IOWA, USA);
`1600 Oregon
`Street,
`Muscatine,
`IOWA 52761,
`UNITED STATES
`
`1997-01-21
`
`2031446
`
`PRINCIPAL
`
`1996-10-01
`
`2003997
`
`PRINCIPAL
`
`1996-02-06
`
`1954412
`
`PRINCIPAL
`
`1996-09-03
`
`1998292
`
`PRINCIPAL
`
`

`

`Serial Number
`
`Word
`mark
`
`Image
`
`Status
`
`Goods/Services (Truncated)
`
`Basis
`
`Filed Date
`
`Int. Class
`
`Owner
`
`Priority
`Date
`
`Reg. Date
`
`Reg. No.
`
`Reg. Type
`
`Su